Managing thrombotic risk in patients with diabetes
Abstract It is well known that diabetes is a prominent risk factor for cardiovascular (CV) events. The level of CV risk depends on the type and duration of diabetes, age and additional co-morbidities. Diabetes is an independent risk factor for atrial fibrillation (AF) and is frequently observed in p...
Main Authors: | A. John Camm, Hani Sabbour, Oliver Schnell, Francesco Summaria, Atul Verma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12933-022-01581-x |
Similar Items
-
Frequency of atrial thrombus formation in patients with atrial fibrillation under treatment with non-vitamin K oral anticoagulants in comparison to vitamin K antagonists: a systematic review and meta-analysis
by: Stefan Reers, et al.
Published: (2018-10-01) -
Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
by: Alfredo Caturano, et al.
Published: (2019-09-01) -
Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program
by: Rabih R. Azar, et al.
Published: (2021-06-01) -
Novel Oral Anti Coagulants (NOACs) as Anti Thrombotic on Atrial Fibrillation Patients
by: Abed Nego Okthara Sebayang
Published: (2020-02-01) -
Direct Acting Oral Anticoagulant vs. Warfarin in the Prevention of Thromboembolism in Patients With Non-valvular Atrial Fibrillation With Valvular Heart Disease—A Systematic Review and Meta-Analysis
by: Januar Wibawa Martha, et al.
Published: (2021-12-01)